[1]
Suryono, S. et al. 2025. In silico studies on quercetin, myricetin, and kaempferol in inhibiting TGF-β1 and galectin-3 for cardiac fibrosis management. Narra J. 5, 1 (Jan. 2025), e1310. DOI:https://doi.org/10.52225/narra.v5i1.1310.